168 related articles for article (PubMed ID: 14530356)
41. Differential function of CD80- and CD86-transfected human melanoma cells in the presence of IL-12 and IFN-gamma.
Rudy W; Gückel B; Siebels M; Lindauer M; Meuer SC; Moebius U
Int Immunol; 1997 Jun; 9(6):853-60. PubMed ID: 9199968
[TBL] [Abstract][Full Text] [Related]
42. CD80 costimulation is required for Th2 cell cytokine production but not for antigen-specific accumulation and migration into the lung.
Harris NL; Prout M; Peach RJ; Fazekas de St Groth B; Ronchese F
J Immunol; 2001 Apr; 166(8):4908-14. PubMed ID: 11290768
[TBL] [Abstract][Full Text] [Related]
43. Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection.
Miyahira Y; Katae M; Kobayashi S; Takeuchi T; Fukuchi Y; Abe R; Okumura K; Yagita H; Aoki T
Infect Immun; 2003 Jun; 71(6):3131-7. PubMed ID: 12761091
[TBL] [Abstract][Full Text] [Related]
44. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells.
Cederbom L; Hall H; Ivars F
Eur J Immunol; 2000 Jun; 30(6):1538-43. PubMed ID: 10898488
[TBL] [Abstract][Full Text] [Related]
45. CD40 ligation induced phenotypic and functional expression of CD80 by human cardiac microvascular endothelial cells.
Jollow KC; Zimring JC; Sundstrom JB; Ansari AA
Transplantation; 1999 Aug; 68(3):430-9. PubMed ID: 10459548
[TBL] [Abstract][Full Text] [Related]
46. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties.
Vasu C; Wang A; Gorla SR; Kaithamana S; Prabhakar BS; Holterman MJ
Int Immunol; 2003 Feb; 15(2):167-75. PubMed ID: 12578846
[TBL] [Abstract][Full Text] [Related]
47. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB
J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797
[TBL] [Abstract][Full Text] [Related]
48. CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis.
Maue AC; Waters WR; Palmer MV; Whipple DL; Minion FC; Brown WC; Estes DM
Vaccine; 2004 Dec; 23(6):769-79. PubMed ID: 15542201
[TBL] [Abstract][Full Text] [Related]
49. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes.
Kim JJ; Bagarazzi ML; Trivedi N; Hu Y; Kazahaya K; Wilson DM; Ciccarelli R; Chattergoon MA; Dang K; Mahalingam S; Chalian AA; Agadjanyan MG; Boyer JD; Wang B; Weiner DB
Nat Biotechnol; 1997 Jul; 15(7):641-6. PubMed ID: 9219266
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.
Kojima Y; Xin KQ; Ooki T; Hamajima K; Oikawa T; Shinoda K; Ozaki T; Hoshino Y; Jounai N; Nakazawa M; Klinman D; Okuda K
Vaccine; 2002 Jul; 20(23-24):2857-65. PubMed ID: 12126895
[TBL] [Abstract][Full Text] [Related]
51. Sequence analyses of feline B7 costimulatory molecules.
Choi IS; Hash SM; Winslow BJ; Collisson EW
Vet Immunol Immunopathol; 2000 Mar; 73(3-4):219-31. PubMed ID: 10713336
[TBL] [Abstract][Full Text] [Related]
52. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
[TBL] [Abstract][Full Text] [Related]
53. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
54. Protein transfer of the costimulatory molecule, B7-2 (CD86), into tumor membrane liposomes as a novel cell-free vaccine.
Westerman LE; Jensen PE
J Immunol Methods; 2000 Mar; 236(1-2):77-87. PubMed ID: 10699581
[TBL] [Abstract][Full Text] [Related]
55. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus.
Liu MF; Li JS; Weng TH; Lei HY
Scand J Immunol; 1999 Jan; 49(1):82-7. PubMed ID: 10023862
[TBL] [Abstract][Full Text] [Related]
56. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
Schweitzer AN; Sharpe AH
J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
[TBL] [Abstract][Full Text] [Related]
57. Nippostrongylus brasiliensis can induce B7-independent antigen-specific development of IL-4-producing T cells from naive CD4 T cells in vivo.
Liu Z; Liu Q; Pesce J; Whitmire J; Ekkens MJ; Foster A; VanNoy J; Sharpe AH; Urban JF; Gause WC
J Immunol; 2002 Dec; 169(12):6959-68. PubMed ID: 12471130
[TBL] [Abstract][Full Text] [Related]
58. Costimulatory molecules CD80 and CD86 in the rat; tissue distribution and expression by antigen-presenting cells.
Damoiseaux JG; Yagita H; Okumura K; van Breda Vriesman PJ
J Leukoc Biol; 1998 Dec; 64(6):803-9. PubMed ID: 9850164
[TBL] [Abstract][Full Text] [Related]
59. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
[TBL] [Abstract][Full Text] [Related]
60. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.
Barouch DH; Santra S; Tenner-Racz K; Racz P; Kuroda MJ; Schmitz JE; Jackson SS; Lifton MA; Freed DC; Perry HC; Davies ME; Shiver JW; Letvin NL
J Immunol; 2002 Jan; 168(2):562-8. PubMed ID: 11777947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
